PERINATAL PREDICTORS OF NEURODEVELOPMENTAL OUTCOMES IN HIGH-RISK NEONATES
Abstract
Background: Thanks to advancements in neonatal medicine, perinatal morbidity has been significantly reduced, but the number of high-risk neonates continues to rise. Efforts to predict neurodevelopmental outcomes at an early age remain limited. The aim of this study was to analyze perinatal predictors of neurodevelopmental outcomes in high-risk neonates.
Methods: A prospective, longitudinal two-year study was conducted at the Pediatric Clinic of the University Clinical Center in Tuzla. The study included 151 neonates, with 99 in the test group (with known perinatal risk factors) and 52 in the control group (without risk factors). Early neurodevelopment was assessed using the Alberta Infant Motor Scale (AIMS). Standard statistical methods were applied for data processing. The study was approved by the Institutional Ethics Committee.
Results: Of the 151 neonates observed, 108 (71.5%) had normal neurodevelopment at 18 months, 29 (19.2%) had mild disorders, and 14 (9.3%) had developmental delays. In the group with suboptimal neurodevelopment, significantly more twin pregnancies, health problems during pregnancy, unnatural births, artificial fertilization, and pregnancy complications were recorded. In neonates, there were significantly more premature births, hypoxic-ischemic encephalopathy, and intracranial hemorrhages. Significant correlations were found between the mother’s age and parity and delayed neurodevelopment. Additionally, correlations were found between birth weight, gestational age, Apgar score, length of hospitalization, and NICU stay with neurodevelopmental delay. Gestational age and the Apgar score at 1 minute showed significant negative predictive value for neurodevelopmental delay.
Conclusion: Prematurity and perinatal asphyxia remain the greatest risks for adverse neurodevelopmental outcomes in neonates. These factors should be the focus of continued medical research and clinical practice. Neonates at the highest risk of developmental delay and their families should be prioritized for early identification, long-term follow-up, and timely interventions.
References
Spittle AJ, Anderson PJ, Tapawan SJ, Doyle LW, Cheong JLY. Early developmental screening and intervention for high-risk neonates - From research to clinical benefits. Semin Fetal Neonatal Med. 2021;26(3):101203. doi: 10.1016/j.siny.2021.101203.
Rogers Michael GH. Risk registers and early detection of handicaps. Develop Med Child Neurol. 1968; 10: 651-61. doi: 10.1111/j.1469-8749.1968.tb02952.x.
Matijević V, Marunica Karšaj J. Smjernice (re)habilitacije djece s neurorazvojnim poremećajima. Fiz Rehabil Med. 2015;27 (3-4):302-29. [Article in Croatian].
Duncan AF, Matthews MA. Neurodevelopmental outcomes in early childhood. Clin Perinatol. 2018;45(3):377-92. doi: 10.1016/j.clp.2018.05.001.
Russ JB, Ostrem BEL. Acquired brain injuries across the perinatal spectrum: pathophysiology and emerging therapies. Pediatr Neurol. 2023;148:206-14. doi: 10.1016/j.pediatrneurol.2023.08.001.
Kuppala VS, Tabangin M, Haberman B, Steichen J, Yolton K. Current state of high‐risk infant follow‐up care in the United States: results of a national survey of academic follow‐up programs. J Perinatol. 2012;32(4):293‐8. doi: 10.1038/jp.2011.97.
Sheridan MD. Infants at risk of handicapping conditions. Mon Bull Minist Health Public Health Lab Serv. 1962;21:238-45.
Hadders‐Algra M. Early diagnostics and early Intervention in neurodevelopmental disorders‐age‐dependent challenges and opportunities. J Clin Med. 2021;10(4):861. doi: 10.3390/jcm10040861.
Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom‐Hernandez J, et al. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr. 2017;171(9):897‐907. doi: 10.1001/jamapediatrics.2017.1689.
Morgan C, Fetters L, Adde L, Badawi N, Bancale A, Boyd RN, et al. Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy: international clinical practice guideline based on systematic reviews. JAMA Pediatr. 2021;175(8):846-58. doi: 10.1001/jamapediatrics.2021.0878.
Tskimanauri N, Khachapuridze N, Imnadze P, Chanadiri T, Bakhtadze S. Correlation between perinatal risk factors and neurodevelopmental outcomes in children at 24 months of age. Georgian Med News. 2018;279:56-61.
Piper MC, Pinnell LE, Darrah J, Maguire T, Byrne PJ. Construction and validation of the Alberta Infant Motor Scale (AIMS). Can J Public Health. 1992; 83(Suppl 2): 46-50.
Darrah J, Bartlett D, Maguire TO, Avison WR, Lacaze‐Masmonteil T. Have infant gross motor abilities changed in 20 years? A re‐evaluation of the Alberta Infant Motor Scale normative values. Dev Med Child Neurol. 2014;56(9):877-81. doi: 10.1111/dmcn.12452.
Piper MC, Darrah J, editors. Motor assessment of the developing infant. 2nd edition. St. Louis, Missouri: Elsevier, Inc., 2022.
World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 79 (4): 373 - 4.
Hadzimuratovic E, Hadzimuratovic A, Pokrajac D, Selimovic A, Muhasilovic S. A predictive value of early clinical parameters for abnormal brain MRI scan in neonates treated with therapeutic hypothermia. Sanamed. 2022; 17(1): 11–15. doi: 10.5937/sanamed17-36698.
Liu TY, Chang JH, Peng CC, Hsu CH, Jim WT, Lin JY, et al. Predictive validity of the Bayley‐III Cognitive Scores at 6 months for cognitive outcomes at 24 months in very‐low‐birth‐weight infants. Front Pediatr. 2021;9:638449. doi: 10.3389/fped.2021.638449.
Kalstabakken AW, Molitor SJ, Gross AC, Georgieff MK, Boys CJ. Predictive value of developmental assessment in a neonatal intensive care unit (NICU) follow‐up clinic. J Pediatr Psychol. 2021;46(7):814‐23. doi: 10.1093/jpepsy/jsab048.
Armstrong-Wells J, Bernard TJ, Boada R, Manco-Johnson M. Neurocognitive outcomes following neonatal encephalopathy. NeuroRehabilitation. 2010;26(1):27-33. doi: 10.3233/NRE-2010-0533.
Tan AP, Svrckova P, Cowan F, Chong WK, Mankad K. Intracranial hemorrhage in neonates: A review of etiologies, patterns and predicted clinical outcomes. Eur J Paediatr Neurol. 2018;22(4):690-717. doi: 10.1016/j.ejpn.2018.04.008.
Hadzic D, Skokic F, Brkic S, Saracevic A. Clinical and laboratory characteristics of neonatal Candida sepsis. Sanamed. 2019; 14(3): 259–67. 10.24125/sanamed.v14i3.364.
Chattopadhyay N, Mitra K. Neurodevelopmental outcome of high risk newborns discharged from special care baby units in a rural district in India. J Public Health Res. 2015;4(1):318. doi: 10.4081/jphr.2015.318.
Hee Chung E, Chou J, Brown KA. Neurodevelopmental outcomes of preterm infants: a recent literature review. Transl Pediatr. 2020;9(Suppl 1):S3-S8. doi: 10.21037/tp.2019.09.10.
Copyright (c) 2024 Sanamed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal Sanamed is published under an Open Access license. All its content is available free of charge. Users can read, download, copy, distribute, print, search the full text of articles, as well as establish HTML links to them, without having to seek the consent of the author or publisher.
The right to use content without consent does not release the users from the obligation to give the credit to the journal and its content in a manner described under CC BY.